Position history for VIKING GLOBAL INVESTORS LP's holdings in BRIDGEBIO PHARMA INC
VIKING GLOBAL INVESTORS LP holds 14.4M shares of BBIO (BRIDGEBIO PHARMA INC), worth $1.1B as of 2025-Q4. The position was decreased (-9.9% shares). BBIO represents 2.9% of VIKING GLOBAL INVESTORS LP's portfolio.
Current Value
$1.1B
Current Shares
14.4M
Total Value Change
+$464.7M
Total Shares Change
-10.7M
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 14.4M |
-9.9% |
| $1.1B |
| 2.9% |
| $75.48 |
0 |
| 2025-Q3 | Decreased | 16M | -13.9% | $829.9M | 2.2% | $51.96 | 0 |
| 2025-Q2 | Decreased | 18.6M | -15.9% | $801.2M | 2.3% | $44.86 | 0 |
| 2025-Q1 | Decreased | 22.1M | -12.2% | $762.5M | 2.4% | $35.11 | 0 |
| 2024-Q4 | Unchanged | 25.1M | 0.0% | $689.3M | 2.2% | $27.32 | 0 |
| 2024-Q3 | Unchanged | 25.1M | 0.0% | $639.6M | 2.3% | $24.94 | 0 |
| 2024-Q2 | Unchanged | 25.1M | 0.0% | $636.3M | 2.4% | $25.33 | 0 |